You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021280015
Dec 202196012
Jan 202274015
Feb 202284017
Mar 2022324017
Apr 202296032
May 202248041
Jun 2022116021
Jul 20227608
Aug 202266027
Sep 202228027
Oct 202252012
Nov 202284030
Dec 20222600
Jan 20232605
Feb 20231003
Mar 20233003
Apr 202352010
May 20232607
Jun 202326011
Jul 202340010
Aug 202348010
Sep 20235209
Oct 20234208
Nov 202366019
Dec 202388011
Jan 20246004
Feb 20244404
Mar 202480029
Apr 202474014
May 202468016
Jun 202453011
Jul 20243604
Aug 202434010
Sep 20249109
Oct 202440027
Nov 202460015
Total25960523